Company news
DiaMedica Therapeutics Inc. news in 2020
DiaMedica Therapeutics Inc.'s news releases, calls and decks from 2020, newest first.
DiaMedica Therapeutics Announces Enrollment of Last Patient in Diabetic Kidney Disease Cohort of Phase 2 REDUX CKD Study
December 14, 2020
DiaMedica Therapeutics Announces Successful Type B Meeting with FDA for the Study of DM199 in Patients with Acute Ischemic Stroke
December 9, 2020
DiaMedica Provides a Business Update and Third Quarter 2020 Financial Results
November 3, 2020
DiaMedica Therapeutics to Report Third Quarter 2020 Financial Results and Provide a Business Update November 5, 2020
October 27, 2020
DiaMedica Announces First Patients Dosed in Diabetic Kidney Disease Cohort in Phase II REDUX CKD Clinical Study
September 13, 2020
DiaMedica Provides a Business Update and Second Quarter 2020 Financial Results
August 10, 2020
DiaMedica Announces Closing of $23 Million Public Offering of Common Shares
August 9, 2020
DiaMedica Announces Pricing of $20 Million Public Offering of Common Shares
August 5, 2020
DiaMedica Announces Proposed Public Offering of Common Shares
August 4, 2020
DiaMedica Announces Positive Results in Top-Line Data from the Phase II ReMEDy Acute Ischemic Stroke Study and Provides a Business Update and First Quarter 2020 Financial Results
May 12, 2020
DiaMedica Announces Positive Results in Top-Line Data From the Phase II ReMEDy Acute Ischemic Stroke Study
May 12, 2020
DiaMedica Therapeutics to Report First Quarter 2020 Financial Results and Provide a Business Update May 14, 2020
May 6, 2020
DiaMedica Therapeutics Announces 2019 Financial Results and Provides Business Update
March 22, 2020
DiaMedica Therapeutics Announces Closing of $8.5 Million Public Offering of Common Shares
February 12, 2020
DiaMedica Announces Pricing of Public Offering of Common Shares
February 10, 2020
Calls in 2020
Decks in 2020
- Technical Presentation (May 2020)
Technical · 26 slides · May 13, 2020